Furthermore, the use of antisense oligonucleotides (ASO), which vary in target sequence-specific regions of hTERT or hTR, yields merit from the ability to retain cell viability and telomere length while disengaging telomerase’s ability to promote cancer development [220,221,222]. Here, TERC is linked to cancer.